ICONHome   ICONContact us   ICONAdd Favorites
Biochemtek
Search Product
Live Chat E-mail
Pharmacology
ICON Inhibitors
ICON Receptors
ICON Hedgehog Signaling Pathway
ICON Stem Cells & Wnt
ICON Signal Transduction
   More +
Research Area
ICON Cancer
ICON Antivirus
ICON Cardiovascular System
ICON Endocrinology
ICON Neuroscience
   More +
Product Type
ICON Natural Products
ICON Peptides
ICON Prostaglandins
ICON Vitamin D series compounds
ICON Toxins
   More +
Browse Alphabetically by Name
ALL A B C D E F
G H I J K L M
N O P Q R S T
U V W X Y Z Others
 
ICONC14307 Ursodeoxycholic acid (128-13-2)
 
 
Catalog No.: C14307
CAS No.: 128-13-2
Synonym: Ursodeoxycholic acid; UDCS
Chemical Name:
(3α,​5β,​7β)​-3,​7-​dihydroxy-cholan-​24-​oic acid
Molecular Formula: C24H40O4
Molecular Weight: 392.57
 
Technical Data:
Appearance:
Solubility: Soluble in DMSO and Ethanol
Purity:
Storage: at -20℃ 2 years
Original QC Data:
Shipping Conditions: Ambient Temp.
 
Price and Availability of Ursodeoxycholic acid:

Size

Price

Stock

10mg 

USD

In Stock 

25mg 

USD

In Stock 

50mg 

USD

In Stock 

Contact us for competitive discounts on bulk quantities

 
Biological Activity:

Ursodiol reduces cholesterol absorption and is used to dissolve gallstones.

Ursodiol, also known as ursodeoxycholic acid and the abbreviation UDCA, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery. The drug is very expensive, however, and if the patient stops taking it, the gallstones tend to recur if the condition that gave rise to their formation does not change. For these reasons, it has not supplanted surgical treatment by cholecystectomy.
Ursodeoxycholic acid is currently the only established drug for the treatment of chronic cholestatic liver diseases. It has cytoprotective, anti-apoptotic, membrane stabilizing, anti-oxidative and immunomodulatory effects. Prolonged administration of ursodeoxycholic acid in patients with primary biliary cirrhosis (PBC) is associated with survival benefit and a delaying of liver transplantation.

 
References:
1. Jackson H, et al. Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. 2007 Oct;46(4):1131-7.


2. Kumar D, et al. Use of ursodeoxycholic acid in liver diseases. J Gastroenterol Hepatol. 2001 Jan;16(1):3-14.

 
View Related Products by Target:
Rapamycin(Sirolimus)
Bexarotene(LGD-1069)
Etoposide(VP-16)
Angoroside C
Cyclosporin C
Oxaliplatin(Eloxatin)
Deferasirox
Geniposide
WZ 4002(WZ-4002)
Pranoprofen
Glimepiride(Amaryl)
Exemestane(FCE-24304,AROMASIN)
 
 

Keywords: Buy Ursodeoxycholic acid | Ursodeoxycholic acid Supplier | Purchase Ursodeoxycholic acid | Ursodeoxycholic acid Cost | Ursodeoxycholic acid  Manufacturer | Order Ursodeoxycholic acid | Ursodeoxycholic acid Distributor | Ursodeoxycholic acid Structure, Chembest

Buy 128-13-2| 128-13-2 Supplier | Purchase 128-13-2 | 128-13-2 Cost | 128-13-2 Manufacturer | Order 128-13-2 | 128-13-2 Distributor | 128-13-2 Structure, Chembest  

Products are for research use only. Not for human use. We do not sell to patients.
Copyright © 2010-2024 Chembest Research Laboratories. All Rights Reserved
E-mail:sales@biochembest.com